We are live on ! Find out more
TL

Tirschwell & Loewy Portfolio holdings

AUM $731M
1-Year Est. Return 15.44%
This Fund
S&P 500
This Quarter Est. Return
-8.24%
1 Year Est. Return
+15.44%
3 Year Est. Return
+77.99%
5 Year Est. Return
+97.61%
10 Year Est. Return
AUM
$531M
AUM Growth
-$61.5M
Cap. Flow
-$2.36M
Cap. Flow %
-0.44%
Top 10 Hldgs %
41.63%
Holding
83
New
3
Increased
23
Reduced
40
Closed
3

Top Buys

Rank Stock Value
1
CPHD
Cepheid Inc
CPHD
+$2.16M
2
TIF
Tiffany & Co.
TIF
+$702K
3
PAYX icon
Paychex
PAYX
+$322K
4
AAPL icon
Apple
AAPL
+$238K
5
PFE icon
Pfizer
PFE
+$235K

Top Sells

Rank Stock Value
1
DXCM icon
DexCom
DXCM
+$1.32M
2
NKTR icon
Nektar Therapeutics
NKTR
+$1.23M
3
SSYS icon
Stratasys
SSYS
+$620K
4
BF.B icon
Brown-Forman Class B
BF.B
+$463K
5
NVO
Novo Nordisk
NVO
+$324K

Sector Composition

Rank Sector Weight
1 Healthcare 38.01%
2 Technology 11.94%
3 Industrials 11.93%
4 Consumer Staples 9.32%
5 Energy 4.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BIIB icon
1
Biogen
BIIB
$29.5B
$29.3M 5.51%
100,286
-835
-0.8% -$276K
TIF
2
DELISTED
Tiffany & Co.
TIF
$27.5M 5.17%
355,536
+8,020
+2% +$702K
BF.B icon
3
Brown-Forman Class B
BF.B
$12.1B
$24.3M 4.59%
784,997
-14,194
-2% -$463K
DXCM icon
4
DexCom
DXCM
$29.2B
$22.1M 4.17%
1,031,780
-59,320
-5% -$1.32M
DHR icon
5
Danaher
DHR
$142B
$21.8M 4.11%
380,671
-30
-0% -$1.77K
NVO
6
Novo Nordisk
NVO
$219B
$21.6M 4.07%
796,260
-11,450
-1% -$324K
JNJ icon
7
Johnson & Johnson
JNJ
$599B
$20.9M 3.93%
223,719
-1,165
-0.5% -$113K
ADI icon
8
Analog Devices
ADI
$181B
$19.4M 3.65%
343,581
+90
+0% +$5.23K
CGNX icon
9
Cognex
CGNX
$10.5B
$17.7M 3.34%
1,031,640
+1,200
+0.1% +$23.8K
NEOG icon
10
Neogen
NEOG
$2.18B
$16.4M 3.09%
971,349
-6,360
-0.7% -$125K
GWW icon
11
W.W. Grainger
GWW
$64.7B
$16.2M 3.06%
75,570
+50
+0.1% +$11.2K
HON icon
12
Honeywell
HON
$71.7B
$15.9M 2.99%
186,449
-1,864
-1% -$170K
RTN
13
DELISTED
Raytheon Company
RTN
$15.8M 2.98%
144,616
-320
-0.2% -$33.4K
HSIC icon
14
Henry Schein
HSIC
$9.82B
$14.2M 2.68%
273,765
-1,989
-0.7% -$110K
SLB icon
15
SLB Ltd
SLB
$69.4B
$14.1M 2.66%
204,582
+1,750
+0.9% +$139K
IDXX icon
16
Idexx Laboratories
IDXX
$44.5B
$13.6M 2.57%
183,505
-460
-0.3% -$32.9K
AMGN icon
17
Amgen
AMGN
$197B
$12.4M 2.34%
89,767
-450
-0.5% -$70.9K
SYT
18
DELISTED
Syngenta Ag
SYT
$12M 2.25%
187,519
-795
-0.4% -$60.6K
WSM icon
19
Williams-Sonoma
WSM
$26.3B
$11.2M 2.12%
294,190
-4,250
-1% -$173K
CTXS
20
DELISTED
Citrix Systems Inc
CTXS
$9.66M 1.82%
175,025
-125
-0.1% -$7.12K
KMB icon
21
Kimberly-Clark
KMB
$36B
$8.8M 1.66%
80,687
+75
+0.1% +$8.27K
ROST icon
22
Ross Stores
ROST
$75.6B
$8.46M 1.59%
174,500
-1,230
-0.7% -$62.8K
GE icon
23
GE Aerospace
GE
$354B
$8.19M 1.54%
67,795
-332
-0.5% -$40.7K
ABBV icon
24
AbbVie
ABBV
$448B
$7.69M 1.45%
141,315
+650
+0.5% +$42.3K
STT icon
25
State Street
STT
$50.2B
$7.43M 1.4%
110,555
-235
-0.2% -$17.5K

Similar funds

Tirschwell & Loewy's Q3 2015 Portfolio in Review

As of Q3 2015, Tirschwell & Loewy held 83 positions worth $531M, down 10% from $592M the previous quarter. Its ten largest holdings account for 42% of the portfolio.

Tirschwell & Loewy's Q3 2015 filing shows 3 new, 23 increased, 40 reduced and 3 closed positions. Its largest new stake was Cepheid Inc: 40,475 shares worth $1.83M. The largest sale was DexCom, an estimated $1.32M.

By sector, the portfolio is most concentrated in Healthcare at 38% of assets, up from 37% a quarter earlier, followed by Technology and Industrials.

  • Tirschwell & Loewy's largest Q3 2015 buy was Cepheid Inc: 40,475 shares worth $1.83M.
  • Tirschwell & Loewy added most to Tiffany & Co. in Q3 2015, an estimated $702K increase.
  • Tirschwell & Loewy's biggest Q3 2015 reduction was DexCom, cutting an estimated $1.32M.
  • Tirschwell & Loewy fully exited The Gap Inc in Q3 2015, selling an estimated $252K.
  • Tirschwell & Loewy's ten largest holdings make up 42% of its $531M portfolio in Q3 2015.
  • Tirschwell & Loewy opened 3 new positions and closed 3 in Q3 2015.
  • Tirschwell & Loewy's portfolio value fell 10% quarter-over-quarter to $531M.

Based on Tirschwell & Loewy's 13F filing for Q3 2015, filed 29 Oct 2015.